La Jolla Pharmaceutical Company

NasdaqCM:LJPC Stock Report

Mkt Cap: US$155.1m

La Jolla Pharmaceutical Financial Health

How is La Jolla Pharmaceutical's financial position?

Financial Health Score

0/6

Financial Health Score 0/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: LJPC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: LJPC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: LJPC has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: LJPC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Debt Coverage: LJPC's debt is not well covered by operating cash flow (10.5%).

Interest Coverage: Insufficient data to determine if LJPC's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies